Fate Therapeutics FATE
$ 1.69
1.51%
Quarterly report 2024-Q3
added 11-12-2024
Fate Therapeutics EV/EBITDA Ratio 2011-2024 | FATE
Annual EV/EBITDA Ratio Fate Therapeutics
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-25.4 | -62 | -16.9 | -9.92 | -7.75 | -0.333 | -0.303 | -3.07 | 0.9 | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
0.9 | -62 | -13.9 |